|
Evaluating DyNamic Myocardial Blood Flow QUantitation As a Cost Effective Care ModeL for DiabEtic Patients With Coronary Artery DiSease
RECRUITINGN/ASponsored by National Heart Centre Singapore
Actively Recruiting
PhaseN/A
SponsorNational Heart Centre Singapore
Started2022-03-15
Est. completion2025-03
Eligibility
Age21 Years – 90 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05343884
Summary
This will be a prospective randomized clinical trial comprising of n=300 diabetic patients, randomized to either dynamic (n=150) or conventional MPI (n=150) strategy. Healthcare resources utilization of each patient will be tracked. Patients will be followed up for short term outcomes and for long term outcomes.
Eligibility
Age: 21 Years – 90 YearsHealthy volunteers accepted
Inclusion Criteria: * Diabetic patients without known coronary artery disease referred for MPI Exclusion Criteria: * History of percutaneous coronary intervention, coronary artery bypass graft surgery * Asthma * Chronic obstructive pulmonary disease (COPD) * Presence of cardiac devices such as pacemakers and implantable cardiac defibrillators
Conditions4
Coronary Artery DiseaseDiabetesDiabetes MellitusHeart Disease
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorNational Heart Centre Singapore
Started2022-03-15
Est. completion2025-03
Eligibility
Age21 Years – 90 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05343884